Abstract Individual phenotypes with respect to drug response or toxicity often result from genetic variations that alter drug metabolism. We have been focusing on genomic loci that encode various enzymes and transporters involved in the metabolism of drugs, and have described more than 1200 single-nucleotide polymorphisms (SNPs) and other variations. Regarding the carbohydrate sulfotransferase (CHST) gene family, we have already constructed highdensity SNP maps of three genomic segments that included CHST2, CHST4, and CHST5, providing a total of 28 SNPs for those loci. In the present study, we screened DNA from 48 healthy Japanese volunteers for SNPs at the CHST1 and CHST3 gene loci, by means of direct sequencing combined with a polymerase chain reaction method for amplifying genomic DNA, and characterized 77 SNPs and four insertion-deletion polymorphisms. The collection of human variations presented here adds to the archive of tools now available for investigating complex genetic diseases, population migration patterns, and a variety of pharmacogenetic possibilities.
Introduction
Sulfotransferases constitute a large family of enzymes that catalyze transfer of the sulfonate group from 3Ј phosphoadenosine 5Ј phosphosulfate to a suitable hydroxyl group or other moiety on an acceptor substrate to form either a sulfate ester or a sulfamate (Falany and Wilborn 1994) . In general, two classes of sulfotransferases are recognized, cytosolic sulfotransferases and carbohydrate sulfotransferases (CHSTs), which are distinct both structurally and with respect to biological function. Sulfotransferases in the cytosol play important roles in the biotransformation, detoxification, or elimination of many compounds, including hormones, neurotransmitters, bile acids, and catabolic end products of drugs. In contrast, CHSTs are resident transmembrane enzymes of the Golgi network that recognize glycans attached to lipids and proteins passing through the secretory pathway (see reviews by Bowman and Bertozzi 1999; Habuchi 2000; Hemmerich and Rosen 2000) . CHSTs are known to play a fundamental role in extracellular signaling and adhesion by generating unique ligands from a carbohydrate scaffold. In this sense, these enzymes might be similar in function to the tyrosine sulfotransferase, also resident in Golgi compartments, that modulates the activity of both secreted and membraneassociated proteins by sulfating tyrosine.
Human CHST1 was originally isolated as the homolog of chick chondroitin 6-sulfotransferase (C6ST) that catalyzes sulfation of chondroitin, keratan sulfate, and sialyl Nacetyllactosamine oligosaccharides (Fukuta et al. 1997; Mazany et al. 1998; Li and Tedder 1999) . CHST1 shows 34% homology with chick C6ST on the amino acid level and may function to reconstitute the high endothelial cell ligand for L-selectin (Bistrup et al. 1999) . Human CHST3 encodes a type II transmembrane protein that shares 74% and 36% identity, respectively, with chick C6ST and human CHST1 (Fukuta et al. 1998; Tsutsumi et al. 1998) . Recombinant human CHST3 displays C6ST activity with a marked specificity for a GlcA-GalNAc sequence. In addition, CHST3 catalyzes sulfation of position 6 of the Gal residue of keratan sulfate, as do chick C6ST and human CHST1.
In this study, we provide high-resolution maps of the human CHST1 and CHST3 gene loci, in which we detected a total of 77 single-nucleotide polymorphisms (SNPs) and four insertion-deletion polymorphisms among 96 chromosomes from a representative Japanese population sample.
Subjects and methods
Blood samples were obtained with written informed consent from 48 healthy Japanese volunteers for this study, which was approved by the ethical committee of the RIKEN SNP Research Center. On the basis of genomic sequences from the GenBank database (accession numbers CHST1 NT-008982.3, CHST3 AC073370.3, and AC022392.4), we designed primers to amplify each gene in its entirety, as well as 2 kb upstream of the first exon and downstream of the last exon. However, most regions corresponding to repetitive sequences were excluded. Protocols for polymerase chain reaction experiments and DNA sequencing are available from our worldwide website (http://snp.ims.u-tokyo.ac.jp/). The gene symbols CHST1 and CHST3 conform to official nomenclatures set out by HUGO/GDB Nomenclature Committees (http:// www.gene.ucl.ac.uk/nomenclature/) and by Li and Tedder (1999) .
Results and discussion
A total of 77 SNPs were identified within the CHST1 and CHST3 gene loci among 48 Japanese volunteers. The exonic organization of each gene and locations of identified SNPs are illustrated schematically in Fig. 1 ; detailed information is given in Table 1 . After comparing our data with SNPs deposited in the dbSNP database in the National Center for Other genes that encode drug-metabolizing enzyme genes, e.g., microsomal glutathione S-transferases, are similarly conserved (Iida et al. 2001a-c) . In addition, we also identified four insertion-deletion polymorphisms within the CHST1 and CHST3 gene loci ( Fig. 1 and Table 1 ). Altogether, we have collected a total of 105 SNPs among five CHST genes in the Japanese population. We hope that the virtual experiments made possible by our SNP catalog will accelerate certain aspects of genomic and pharmacogenetic research.
